The effectiveness of chronic pelvic pain treatment in patients with endometriosis depending on the estrogen metabolite levels

In: Гинекология, Vol 15, Iss 4, Pp 16-18 (2013) · 2013 · W3154514696
article OA: green CC0
🔓 Open OA copy View on OpenAlex
AI-generated summary by gemini-2.5-flash-lite, 2026-08-09

This study investigated chronic pelvic pain treatment effectiveness in endometriosis patients, finding dienogest therapy significantly reduced pain in patients with normal estrogen metabolism compared to those with carcinogenic estrogen fractions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This article presents the results of studies 58 patients, mean age 29±1,7 years with chronic pelvic pain and laparoscopically confirmed diagnosis of external genital endometriosis. Based on the research results of estrogen metabolites has been allocated two groups studied patients. Group I – 26 patients (44,8%) with a predominance of carcinogenic fractions of estrogen in the urine of 2-ONE1/16-ONE1 least 2 (average 0,8±0,2), II group – 54 patients (55,2%) with normal estrоgen metabolism (average 2,3±0,3). Against the background of suppressive therapy with dienogest 2 mg after surgery in 12 months was significant (p

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK